Approved Company
AI|ffinity
Address: NO DATA
Website: www.aiffinity.com
Country(s):
Supported Region(s):
Description

AI|ffinity offers a distinctive NMR-AI platform that utilizes proprietary Nuclear Magnetic Resonance (NMR) experiments to determine molecular 3D structures and study molecular interactions. With the support of AI algorithms and Cheminformatics, this platform expedites the 3 early stages of drug discovery: virtual screening & hit discovery, lead optimization, and structure determination. Its rapid 1D NMR screening and 4D NMR protein-drug candidate structure determination have industry-leading speed, cost-effectiveness, and sensitivity. This makes the NMR-AI platform particularly suitable for intrinsically disordered (>30% of eukaryotic proteome) and aggregating protein targets, a unique feature in the market. It also finds applications in protein engineering and antibody design.
 
As a spin-off from Masaryk University (Brno, Czech Republic), we have privileged access to the Central European Institute of Technology (CEITEC) fully-fledged biophysical facilities for our joint drug discovery and bioengineering projects with industrial partners. You can find some cool videos at www.aiffinity.com
 
We recently closed a seed funding round of 1.2M EUR, and we welcome partnerships with biotech and pharma companies, as well as leading academic institutions, to co-develop new drugs, antibodies, engineered proteins, and software solutions.

Service Category(s)
Key Service(s)
Life Science Sector
Certificates
NO DATA